CLINICAL_TRIALS
trial_result
· 2022-01-25
Clinical Trial Update: Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II Study [Phase 2]
Summary
Phase II study update on postoperative adjuvant treatment for completely resected mucosal melanoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Peking University Cancer Hospital & Institute | Conditions: Mucosal Melanoma | Phase 2 | Status: UNKNOWN